Aerosolized antibiotics for treating hospital-acquired and ventilator-associated pneumonia

References

• American Thoracic Society/Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am. J. Respir. Crit. Care171(4), 388–416 (2005).
   PubMed Web of Science ®Google Scholar
• Aarts MAW, Hancock JN, Heyland D, McLeod RS, Marshall JC. Empiric antibiotic therapy for suspected ventilator-associated pneumonia: a systematic review and meta-analysis of randomized trials. Crit. Care Med.36(1), 108–117 (2008).
   PubMed Web of Science ®Google Scholar
• Kiem S, Schentag JJ. Interpretation of antibiotic concentration ratios measured in epithelial lining fluid. Antimicrob. Agents Chemother.52(1), 24–36 (2008).
   PubMed Web of Science ®Google Scholar
• Boucher BA, Wood GC, Swanson JM. Pharmacokinetic changes in critical illness. Crit. Care Clin.22(2), 255–271 (2006).
   PubMed Web of Science ®Google Scholar
• Pines A, Raafat H, Plucinski K. Gentamicin and colistin in chronic purulent bronchial infections. Br. Med. J.27(2), 543–545 (1967).
   Google Scholar
• Pines A, Raafat H, Siddiqui GM et al. Treatment of severe Pseudomonas infections of the bronchi. Br. Med. J.14(1), 663–665 (1970).
   Google Scholar
• Klastersky J, Geuning C, Mouawad E et al. Endotracheal gentamicin in bronchial infections in patients with tracheostomy. Chest61(2), 117–120 (1972).
   PubMed Web of Science ®Google Scholar
• Klastersky J, Carpentier-Meunier F, Kahan-Coppens L et al. Endotracheally administered antibiotics for Gram-negative bronchopneumonia. Chest75(5), 586–591 (1979).
   PubMed Web of Science ®Google Scholar
• Sorensen VJ, Horst HM, Obeid FN et al. Endotracheal aminoglycosides in Gram-negative pneumonia: a preliminary report. Am. Surgeon52(7), 391–394 (1986).
   PubMedGoogle Scholar
• Stillwell PC, Kearns GL, Jacobs RF. Endotracheal tobramycin in Gram-negative pneumonitis. Drug Intell. Clin. Pharm.22(7–8), 577–581 (1988).
   PubMedGoogle Scholar
• McCall CY, Spruill WJ, Wade WE. The use of aerosolized tobramycin in the treatment of a resistant pseudomonal pneumonitis. Ther. Drug Monit.11(6), 692–695 (1989).
   PubMed Web of Science ®Google Scholar
• Hallal A, Cohn SM, Namias N et al. Aerosolized tobramycin in the treatment of ventilator-associated pneumonia: a pilot study. Surg. Infect. (Larchmt)8(1), 73–82 (2007).
   PubMedGoogle Scholar
• Mohr AM, Sifri ZC, Horng HS et al. Use of aerosolized aminoglycosides in the treatment of Gram-negative ventilator-associated pneumonia. Surg. Infect. (Larchmt)8(3), 349–357 (2008).
   Google Scholar
• Czosnowski QA, Wood GC, Magnotti LJ et al. Adjunctive aerosolized antibiotics for treatment of ventilator-associated pneumonia. Pharmacotherapy29(9), 1054–1060 (2009).
   PubMed Web of Science ®Google Scholar
• Ghannam DE, Rodriguez GH, Raad II, Safdar A. Inhaled aminoglycosides in cancer patients with ventilator-associated Gram-negative bacterial pneumonia: safety and feasibility in the era of escalating drug resistance. Eur. J. Clin. Microbiol. Infect. Dis.28, 253–259 (2009).
   PubMed Web of Science ®Google Scholar
• Hamer DH. Treatment of nosocomial pneumonia and tracheobronchitis caused by multidrug-resistant Pseudomonas aeruginosa with aerosolized colistin. Am. J. Respir. Crit. Care Med.162(1), 328–330 (2000).
   PubMed Web of Science ®Google Scholar
• Motaouakkil S, Charra B, Hachimi A et al. Colistin and rifampicin in the treatment of nosocomial infections from multiresistant Acinetobacter baumannii. J. Infect.53(4), 274–278 (2006).
   PubMed Web of Science ®Google Scholar
• Sobieszczyk ME, Furuya EY, Hay CM et al. Combination therapy with polymyxin B for the treatment of multidrug-resistant Gram-negative respiratory tract infections. J. Antimicrob. Chemother.54(2), 566–569 (2004).
   PubMed Web of Science ®Google Scholar
• Michalopoulos A, Kasiakou SK, Mastora Z et al. Aerosolized colistin for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis. Crit. Care9(1), R53–R59 (2005).
   PubMed Web of Science ®Google Scholar
• Kwa ALH, Loh CS, Low JGH et al. Nebulized colistin in the treatment of pneumonia due to multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa. Clin. Infect. Dis.41(5), 754–757 (2005).
   PubMed Web of Science ®Google Scholar
• Michalopoulos A, Fotakis D, Virtzili S et al. Aerosolized colistin as adjunctie treatment of ventilator-associated pneumonia due to multidrug-resistant Gram-negative bacteria: a prospective study. Respir. Med.102(3), 407–412 (2008).
   PubMed Web of Science ®Google Scholar
• Lin CC, Liu TC, Kuo CF, Liu CP, Lee CM. Aerosolized colistin for the treatment of multidrug-resistant Acinetobacter baumannii pneumonia: experiences in a tertiary care hospital in northern Taiwan. J. Microbiol. Immunol. Infect.43(4), 323–331 (2010).
   PubMedGoogle Scholar
• Pereira GH, Muller PR, Levin AS. Salvage treatment of pneumonia and initial treatment of tracheobronchitis caused by multidrug-resistant Gram-negative bacilli with inhaled polymyxin B. Diag. Microbiol. Infect. Dis.58, 235–240 (2007).
   PubMed Web of Science ®Google Scholar
• Kofteridis DP, Alexopoulou C, Valachis A et al. Aerosolized plus intravenous colistin versus intravenous colistin alone for the treatment of ventilator-associated pneumonia: a matched case–control study. Clin. Infect. Dis.51(11), 1238–1244 (2010).
   PubMed Web of Science ®Google Scholar
• Horianopoulou M, Lambropoulos S, Papafragas E et al. Effect of aerosolized colistin on multidrug-resistant Pseudomonas aeruginosa in bronchial secretions of patients without cystic fibrosis. J. Chemother.17(5), 536–538 (2005).
   PubMed Web of Science ®Google Scholar
• Berlana D, Llop JM, Fort E et al. Use of colistin in the treatment of multiple-drug resistant Gram-negative infections. Am. J. Health-Syst. Pharm.62(1), 39–47 (2005).
   PubMed Web of Science ®Google Scholar
• Wood GC, Underwood EL, Croce MA, Swanson JM, Fabian TC. Treatment of recurrent Stenotrophomonas maltophilia ventilator-associated pneumonia with doxycycline and aerosolized colistin. Ann. Pharmacother.44(10), 1665–1668 (2010).
   PubMed Web of Science ®Google Scholar
• Stoutenbeek CP, van Saene HKF, Miranda DR et al. Nosocomial Gram-negative pneumonia in critically ill patients: a 3-year experience with a novel therapeutic regimen. Intensive Care Med.12(6), 419–423 (1986).
   PubMedGoogle Scholar
• Wood GC, Swanson JM. Aerosolized antibacterials for the prevention and treatment of hospital-acquired pneumonia. Drugs67(6), 903–914 (2007).
   PubMed Web of Science ®Google Scholar
• MacIntyre NR, Silver RM, Miller CW et al. Aerosol delivery in intubated, mechanically ventilated patients. Crit. Care Med.13(2), 81–84 (1985).
   PubMed Web of Science ®Google Scholar
• Miller DD, Amin MM, Palmer LB et al. Aerosol delivery and modern mechanical ventilation: in vitro/in vivo evaluation. Am. J. Respir. Crit. Care Med.168(10), 1205–1209 (2003).
   PubMed Web of Science ®Google Scholar
• Wood GC, Boucher BA. Aerosolized antimicrobial therapy in acutely ill patients. Pharmacotherapy20(2), 166–181 (2000).
   PubMed Web of Science ®Google Scholar
• Wood GC, Boucher BA, Croce MA et al. Aerosolized ceftazidime for the prevention of ventilator-associated pneumonia and its effects on the inflammatory response in critically ill trauma patients. Pharmacotherapy22(8), 972–982 (2002).
   PubMed Web of Science ®Google Scholar
• Claridge JA, Edwards NM, Swanson JM, Fabian TC, Wood GC, Croce MA. Aerosolized ceftazidime prophylaxis against ventilator-associated pneumonia in high risk trauma patients: the results of a double-blinded randomized study. Surg. Infect. (Larchmt)8(1), 83–90 (2007).
   PubMedGoogle Scholar
• Hakeam HA, Almohaizeie AM. Hypotension following treatment with aerosolized colistin in a patient with multidrug-resistant Pseudomonas aeruginosa. Ann. Pharmcother.40(9), 1677–1680 (2006).
   Google Scholar
• Leong KW, Ong S, Chee HL, Lee W, Kwa AL. Hypersensitivity pneumonitis due to high-dose colistin aerosol therapy. Int. J. Infect. Dis.14(11), 1018–1019 (2010).
   Google Scholar
• Burdette SD, Limkemann AJ, Slaughter JB, Beam WB, Markert RJ. Serum concentrations of aerosolized tobramycin in medical, surgical, and trauma patients. Antimicrob. Agents Chemother.53(10), 4568 (2009).
   PubMed Web of Science ®Google Scholar
• Le J, Ashley ED, Newhauser MM et al. Consensus summary of aerosolized antimicrobial agents: application of guideline criteria. Pharmacotherapy30(6), 562–584 (2010).
   PubMed Web of Science ®Google Scholar
• Luyt CE, Clavel M, Guntupalli K et al. Pharmacokinetics and lung delivery of PDDS-aerosolized amikacin (NKTR-061) in intubated and mechanically ventilated patients with nosocomial pneumonia. Crit. Care13(6), R200 (2009).
   PubMed Web of Science ®Google Scholar